spec sheet10 rows
Hexedrone is a stimulant synthetic cathinone belonging to the same reuptake-inhibiting series as pentedrone, distinguished by its longer alpha-carbon side chain. Structure-activity studies of this scaffold show that such compounds act as selective inhibitors of the dopamine transporter with comparatively little serotonergic activity, yielding a relatively plain, non-entactogenic stimulant effect; potency across the series tracks with side-chain length. Most of the available human and preclinical data concern its more widely used N-ethyl analog, N-ethyl-hexedrone (also called hexen or NEH), which has featured in forensic seizures, controlled pharmacokinetic sampling, driving-under-the-influence casework, and at least one fatal intoxication. Dedicated data on the parent hexedrone itself remain sparse, and it is generally reported as relatively weak compared with more notorious cathinones.
- Mild to moderate stimulation
- Increased alertness and energy
- Appetite suppression
- Dopamine-selective reuptake-inhibiting stimulant
- Raised heart rate and blood pressure
- Insomnia and anxiety
- Redosing potential
Mechanism
Hexedrone is presumed to act mainly as a at the and transporters, elevating these catecholamines without meaningful activity; this gives a straightforward stimulant character. Because it is an obscure compound with limited study, its exact potency and profile are described conservatively.
receptor fingerprint
Reuptake inhibitor
transporterReuptake inhibitor
Safetyrisks and cautions, not medical advice
Even as a milder cathinone it still raises heart rate and blood pressure, can cause anxiety, insomnia, and appetite loss, and can prompt redosing. Its abuse and long-term risks are poorly characterized because so little human data exist, so unknown toxicity is a real concern. It is dangerous to combine with other stimulants or MAOIs. Not medical advice.
Subjective profileweighing the evidence above
Not worth it. Plain dopaminergic stimulation with the usual raised heart rate, insomnia and redosing pull, almost no human data to weigh it against, and nothing on offer that caffeine or a prescribed stimulant does not do better.
Resources
This entry is here for reference.
Research
- 2019first citedStructure-activity relationships of bath salt components: substituted cathinones and benzofuran…
- 2023most recentStructure-Activity Relationship of N-Ethyl-Hexedrone Analogues: Role of the α-Carbon Side-Chain…
- 1.Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters
- 2.Structure-Activity Relationship of N-Ethyl-Hexedrone Analogues: Role of the α-Carbon Side-Chain Length in the Mechanism of Action, Cytotoxicity, and Behavioral Effects in Mice
- 3.GC-MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study.
- 4.Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
- 5.Drug consumption of suspected drug-influenced drivers in Hungary (2016-2018).
5 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
How strong is hexedrone?
It is generally reported as relatively weak compared with cathinones like pentedrone or mephedrone, though data are thin.
Is it entactogenic?
No, it lacks meaningful serotonin activity and behaves as a plain catecholamine stimulant.
Is much known about it?
Very little; it is an obscure research chemical, so its risks are described cautiously and unknown toxicity is a concern.
Limitations of the evidence
- Very limited safety data
Adverse effects
- Raised heart rate and blood pressure
- Insomnia and anxiety
- Redosing potential